The National Eczema Association and Pediatric Dermatology Research Alliance Receive Collaborative Engagement Award from PCORI
Award will support education in patient-centered outcomes research and emerging pediatric eczema therapies.
Award will support education in patient-centered outcomes research and emerging pediatric eczema therapies.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.